广泛性回避性限制性食物摄入障碍表型儿童的精神与躯体共病
ARFID儿童神经发育、胃肠道、内分泌代谢、呼吸、神经及过敏性疾病风险显著升高,精神科诊断数量更多、住院时间更长,且精神疾病诊断更早。
要点
- ARFID儿童共病神经发育障碍风险显著增高,如孤独症HR 9.7、智力障碍HR 10.3。
- ARFID儿童胃肠道、内分泌代谢、呼吸、神经及过敏性疾病风险亦明显升高。
- ARFID儿童精神科诊断数量更多(IRR 4.7)、住院时间更长(IRR 5.5),精神疾病诊断更早。
核心结论
- ARFID儿童存在复杂的精神与躯体共病模式,需所有儿科亚专业关注。
主要发现
- ARFID儿童神经发育、胃肠道、内分泌代谢、呼吸、神经及过敏性疾病风险显著升高,如孤独症HR 9.7(95%CI 7.5-12.5)、智力障碍HR 10.3(95%CI 7.6-13.9)。
- ARFID儿童胃食管反流病HR 6.7(95%CI 4.6-9.9)、垂体疾病HR 5.6(95%CI 2.7-11.3)、慢性下呼吸道疾病HR 4.9(95%CI 2.4-10.1)、癫痫HR 5.8(95%CI 4.1-8.2)。
- ARFID与自身免疫疾病及强迫症风险升高无关。
- ARFID儿童精神科诊断数量更多(IRR 4.7,95%CI 4.0-5.4),住院时间更长(IRR 5.5,95%CI 1.7-17.6),精神疾病诊断更早。
- 未发现性别特异性差异。
临床怎么用
- 儿科各亚专业应关注ARFID患儿,因其共病精神与躯体疾病风险高。
- 对ARFID儿童应评估神经发育、胃肠道、内分泌代谢、呼吸、神经及过敏性疾病。
- ARFID儿童可能需要更长的住院时间及更早的精神健康评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Avoidant restrictive food intake disorder (ARFID) is a feeding and eating disorder characterized by limited variety and/or quantity of food intake impacting physical health and psychosocial functioning. Children with ARFID often present with diverse psychiatric and somatic symptoms and therefore consult various pediatric subspecialties. Large-scale studies mapping coexisting conditions are, however, lacking. OBJECTIVE: To characterize the health care needs of youth with ARFID. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used the Child and Adolescent Twin Study in Sweden (CATSS), in combination with inpatient and specialized outpatient clinical diagnoses from the Swedish National Patient Register. Data were collected from July 2004 to April 2020, and data were analyzed from September 2022 to February 2024. EXPOSURE: Using a composite measure derived from parent or guardian reports and register data, children with the broad ARFID phenotype occurring between the ages of 6 to 12 years were identified, as well as children without ARFID. MAIN OUTCOMES AND MEASURES: From more than 1000 diagnostic International Classification of Diseases (ICD) codes, mental and somatic conditions within or across ICD chapters, the number of distinct per-person diagnoses, and inpatient treatment days between participants' birth and 18th birthdays were specified (90 outcomes). Hazard ratios (HRs) and incidence rate ratios (IRRs) were calculated. RESULTS: Of 30 795 CATSS participants, a total of 616 children (2.0%) with the broad ARFID phenotype occurring between the ages of 6 to 12 years were identified, and 30 179 children without ARFID were identified. Of 616 children with ARFID, 241 children were female (39.1%). Relative risks of neurodevelopmental, gastrointestinal, endocrine or metabolic, respiratory, neurological, and allergic disorders were substantially increased in children with ARFID (eg, autism: HR, 9.7; 95% CI, 7.5-12.5; intellectual disability: HR, 10.3; 95% CI, 7.6-13.9; gastroesophageal reflux disease: HR, 6.7; 95% CI, 4.6-9.9; pituitary conditions: HR, 5.6; 95% CI, 2.7-11.3; chronic lower respiratory diseases: HR, 4.9; 95% CI, 2.4-10.1; and epilepsy: HR, 5.8; 95% CI, 4.1-8.2). ARFID was not associated with elevated risks of autoimmune illnesses and obsessive-compulsive disorder. Children with ARFID had significantly more distinct mental diagnoses (IRR, 4.7; 95% CI, 4.0-5.4) and longer hospital stays (IRR, 5.5; 95% CI, 1.7-17.6) compared with children without ARFID. Children with ARFID were diagnosed with a mental condition earlier than children without ARFID. No sex-specific differences emerged. CONCLUSIONS AND RELEVANCE: This cohort study yields the broadest and most detailed evidence of coexisting mental and somatic conditions in the largest sample of children with ARFID to date. Findings suggest a complex pattern of health needs in youth with ARFID, underscoring the critical importance of attention to the illness across all pediatric specialties.
引用
- Wronski ML, Kuja-Halkola R, Hedlund E, et al. Mental and Somatic Conditions in Children With the Broad Avoidant Restrictive Food Intake Disorder Phenotype. JAMA Pediatr. 2025. PMID: 39960738. doi:10.1001/jamapediatrics.2024.6065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。